These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10378676)

  • 1. Methotrexate-albumin conjugate causes tumor growth delay in Dunning R3327 HI prostate cancer-bearing rats.
    Stehle G; Wunder A; Schrenk HH; Hartung G; Heene DL; Sinn H
    Anticancer Drugs; 1999 Apr; 10(4):405-11. PubMed ID: 10378676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of methotrexate-albumin conjugates in tumor-bearing rats.
    Stehle G; Wunder A; Sinn H; Schrenk HH; Schütt S; Frei E; Hartung G; Maier-Borst W; Heene DL
    Anticancer Drugs; 1997 Oct; 8(9):835-44. PubMed ID: 9402310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-clinical evaluation of a methotrexate-albumin conjugate (MTX-HSA) in human tumor xenografts in vivo.
    Burger AM; Hartung G; Stehle G; Sinn H; Fiebig HH
    Int J Cancer; 2001 Jun; 92(5):718-24. PubMed ID: 11340578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo antitumor activity of methotrexate conjugated to human serum albumin in human cancer cells.
    Wosikowski K; Biedermann E; Rattel B; Breiter N; Jank P; Löser R; Jansen G; Peters GJ
    Clin Cancer Res; 2003 May; 9(5):1917-26. PubMed ID: 12738750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The loading rate determines tumor targeting properties of methotrexate-albumin conjugates in rats.
    Stehle G; Sinn H; Wunder A; Schrenk HH; Schütt S; Maier-Borst W; Heene DL
    Anticancer Drugs; 1997 Aug; 8(7):677-85. PubMed ID: 9311444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of methotrexate-albumin conjugates in rats bearing a Walker-256 carcinoma.
    Wunder A; Stehle G; Schrenk HH; Hartung G; Heene DL; Maier-Borst W; Sinn H
    Int J Cancer; 1998 Jun; 76(6):884-90. PubMed ID: 9626357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Albumin-based drug carriers: comparison between serum albumins of different species on pharmacokinetics and tumor uptake of the conjugate.
    Stehle G; Wunder A; Schrenk HH; Hartung G; Heene DL; Sinn H
    Anticancer Drugs; 1999 Sep; 10(8):785-90. PubMed ID: 10573211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel methotrexate-albumin (mtx-rsa)-conjugate causes significant growth delay of o-342 ovarian-carcinoma in-vivo.
    Steinmann A; Friedrich E; Rath U
    Oncol Rep; 1995 Jan; 2(1):107-9. PubMed ID: 21597699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyethylene glycol conjugates of methotrexate varying in their molecular weight from MW 750 to MW 40000: synthesis, characterization, and structure-activity relationships in vitro and in vivo.
    Riebeseel K; Biedermann E; Löser R; Breiter N; Hanselmann R; Mülhaupt R; Unger C; Kratz F
    Bioconjug Chem; 2002; 13(4):773-85. PubMed ID: 12121133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonist RC-3095 on the growth of the androgen-independent Dunning R-3327-AT-1 rat prostate cancer.
    Pinski J; Reile H; Halmos G; Groot K; Schally AV
    Cancer Res; 1994 Jan; 54(1):169-74. PubMed ID: 7903203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society.
    Hartung G; Stehle G; Sinn H; Wunder A; Schrenk HH; Heeger S; Kränzle M; Edler L; Frei E; Fiebig HH; Heene DL; Maier-Borst W; Queisser W
    Clin Cancer Res; 1999 Apr; 5(4):753-9. PubMed ID: 10213209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of prolactin in modulating the effects of tamoxifen on growth of the Dunning R3327 rat prostate adenocarcinoma.
    Sylvester PW; Ip MM
    Prostate; 1987; 10(1):57-67. PubMed ID: 3822918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of active immunization against luteinizing hormone-releasing hormone on the androgen-sensitive Dunning R3327-PAP and androgen-independent Dunning R3327-AT2.1 prostate cancer sublines.
    Fuerst J; Fiebiger E; Jungwirth A; Mack D; Talwar PG; Frick J; Rovan E
    Prostate; 1997 Jul; 32(2):77-84. PubMed ID: 9215394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of an anti-membrane antibody-methotrexate conjugate on the human prostatic tumour line PC3.
    Rowland AJ; Harper ME; Wilson DW; Griffiths K
    Br J Cancer; 1990 May; 61(5):702-8. PubMed ID: 2337507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of olfactory bulbectomy, melatonin, and/or pinealectomy on three sublines of the Dunning R3327 rat prostatic adenocarcinoma.
    Toma JG; Amerongen HM; Hennes SC; O'Brien MG; McBlain WA; Buzzell GR
    J Pineal Res; 1987; 4(3):321-38. PubMed ID: 3625464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of methotrexate-monoclonal anti-prostatic acid phosphatase antibody conjugate on human prostate tumor.
    Deguchi T; Chu TM; Leong SS; Horoszewicz JS; Lee CL
    Cancer Res; 1986 Aug; 46(8):3751-5. PubMed ID: 3731053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. IV. Therapy of murine melanoma B16 by human serum albumin-methotrexate derivative.
    Bostík J; Bures L; Spundová M
    Neoplasma; 1988; 35(3):343-9. PubMed ID: 3405342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric analysis of R3327 rat prostate adenocarcinoma grown in vivo and in vitro.
    Claflin AJ; Pollack A; Malinin T; Block NL; Irvin GL
    J Natl Cancer Inst; 1982 Jul; 69(1):79-87. PubMed ID: 6954325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. III. Human serum albumin-methotrexate derivative, its preparation and basic testing.
    Bures L; Bostík J; Motycka K; Spundová M; Rehák L
    Neoplasma; 1988; 35(3):329-42. PubMed ID: 3405341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of an aminopterin-albumin conjugate in tumor-bearing rats.
    Kremer P; Hartung G; Bauder-Wüst U; Schrenk HH; Wunder A; Heckl S; Zillmann U; Sinn H
    Anticancer Drugs; 2002 Jul; 13(6):615-23. PubMed ID: 12172507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.